<DOC>
	<DOCNO>NCT02823457</DOCNO>
	<brief_summary>This study implement values-based motivational interviewing ( VBMI ) intervention promote treatment completion fix dose combination ( FDC ) MK-5172/MK-8742 x 12 week among 30 Veterans substance use disorder ( SUD ) treatment naïve genotype 1 chronic hepatitis C virus ( HCV ) infection .</brief_summary>
	<brief_title>VBMI Increase Treatment Completion With MK-MK-5172/MK-8742 Among Veterans With Active Substance Use Disorders Genotype 1 Chronic Hepatitis C</brief_title>
	<detailed_description>The investigator conduct prospective study 30 Veterans treatment-naive genotype 1 chronic hepatitis C infection admit Substance Abuse Residential Rehabilitation Treatment Program ( SARRTP ) G.V . ( Sonny ) Montgomery VA Medical Center . Enrolled veteran treat MK-5172/MI-8742 receive 12 week value base motivational intervention promote completion HCV treatment . MK-5172/MK-8742 prescribed accordance package insert .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Alcohol-Related Disorders</mesh_term>
	<criteria>1 . Identified treatmentnaïve genotype 1 chronic HCV infection ; Veterans genotype 1a must baseline NS5a resistance test 2 . Current resident SARRTP program 3 . Willing initiate treatment FDC MK5172/MK8742 SARRTP 30 day postdischarge . 4 . Willing attend coordinate HCV treatment clinic visit substance abuse aftercare visit every 2 week upon SARRTP discharge 1 . Contraindications therapy FDC MK5172/MK8742 2 . Unable provide write informed consent 3 . Hepatocellular carcinoma medical condition preclude HCV treatment 4 . Acute HCV infection 5 . Prior treatment chronic HCV 6 . History decompensated cirrhosis 7 . Platelet count &lt; 75 K/cmm and/or albumin &lt; 3 grams/dL 8 . Females male sex partner females pregnant , nurse and/or unwilling use contraception 9 . Patients infect genotype 1a undergone baseline NS5a resistance test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>